Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Eero J. Kumpulainen"'
Autor:
Jari Kellokoski, Risto Pirinen, Jukka Virtaniemi, K M Ropponen, Veli-Matti Kosma, Matti Pukkila, Matti Juhola, Ari Kosunen, Reijo Sironen, Risto T. Johansson, Eero J. Kumpulainen, Juhani Nuutinen
Publikováno v:
Oral Oncology. 43:51-59
We investigated the expression of CD44 and MMP-9 in primary oral squamous cell carcinoma (OSCC) and evaluated their association with each other and clinicopathological factors as well as their prognostic value during long term follow up. Histological
Autor:
K M Ropponen, Tero Leinonen, Risto T. Johansson, Veli-Matti Kosma, Jan Böhm, Risto Pirinen, Eero J. Kumpulainen
Publikováno v:
Human Pathology. 36:44-50
Summary The aim of the study was to investigate the expression and prognostic role of versican in 212 patients with resected nonsmall cell lung cancer. Tumor samples were stained immunohistochemically, and the versican staining was evaluated both in
Publikováno v:
European Journal of Cancer. 38:1717-1723
This study aimed to examine the clinical and biological differences in 198 patients with either T1-T2 local glottic or supraglottic squamous cell carcinomas. The patients with supraglottic cancer had a poorer prognosis, as well as more advanced and h
Autor:
Matti Pukkila, Eero J. Kumpulainen, Jukka Virtaniemi, Pirjo Halonen, Veli-Matti Kosma, Ari Kosunen, Risto T. Johansson, Jari Kellokoski, Juhani Nuutinen
Publikováno v:
Head & Neck. 24:784-791
Background The role of p53 expression in human neoplasms is still controversial, and it has been associated with both favorable and unfavorable outcome of the patients. Also cytoplasmic expression of p53 protein has been reported to affect survival i
Autor:
Ulla Geiger, Anneli Piironen, Eero J. Kumpulainen, Tiina Salminen, Seppo Hyvärinen, Anja Salo, Pirkko Peltonen, Alpo Kärkkäinen, Pirkko Heikkinen, R. Kokko, Marja-Liisa Kokko, Irma Saarenmaa, Vesa Kataja, Matti Hakama, Jorma Isola, Juhani Pakkanen, Marja-Liisa Talviala
Publikováno v:
Breast Cancer Research and Treatment. 67:117-123
Purpose. We studied which, age of the patient or density of the breast accounts for the sensitivity of mammography and ultrasonography (US). Furthermore we studied whether the overall impression on the density of the breast or the density in tumour a
Autor:
Matti Pukkila, Veli-Matti Kosma, Risto Pirinen, Risto T. Johansson, Matti Juhola, Eero J. Kumpulainen, Jukka Virtaniemi, Hannu Valtonen
Publikováno v:
Journal of Clinical Pathology. 54:42-47
To investigate the expression of alpha, beta, and gamma catenins in oropharyngeal and hypopharyngeal squamous cell carcinoma and their relations to each other, as well as to clinical data, tumour differentiation, and prognosis.Primary tumours for ana
Publikováno v:
Head & Neck. 23:29-33
Background The pharyngocutaneous fistula is troublesome complication after total laryngectomy. Despite a large number of studies, there is still disagreement on factors predisposing to this complication. Methods A retrospective analysis of pharyngocu
Autor:
Risto Johansson, Pirjo Halonen, Jukka Virtaniemi, Veli-Matti Kosma, L. Salmi, Risto Pirinen, Eero J. Kumpulainen, Pasi Hirvikoski
Publikováno v:
European Journal of Cancer. 35:231-237
The purpose of the current study was to analyse apoptosis and bcl-2 expression in laryngeal squamous cell carcinoma (SCC) with special reference to their prognostic significance, correlation with the clinical and pathological characteristics as well
Autor:
Heikki Helin, Veli-Matti Kosma, Risto T. Johansson, Jukka Virtaniemi, Pasi Hirvikoski, Eero J. Kumpulainen, Matti Juhola, Immo Rantala
Publikováno v:
International Journal of Cancer. 79:546-550
Aberrations in the function of α-catenin (α-cat), the anchoring protein of E-cadherin, are believed to cause dysfunction of the cadherin–catenin complex, leading to disturbed cell–cell adhesion. It has been suggested that expression of α-cat i
Publikováno v:
Anti-Cancer Drugs. 9:131-134
This study is based on 194 patients with primary breast cancer treated with adjuvant CNF combination chemotherapy, who were followed-up for the risk of subsequent neoplasms. During an average follow-up of 4.8 years, 16 cases of new cancers were detec